• It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

ADMA Biologics: "This is a very speculative situation...Any time there's immunity compromised patients, there's some big money down the road."

MP Materials: "This is one of those situations that is very difficult...If they don't pull out of the tailspin of losses, then it just doesn't matter."

Delcath Systems: "There's no investing. At this point, it is speculating."

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Disclaimer

Money Report

news 2 hours ago

A bar is the worst place to meet a potential mate, dating coaches say: Here's where to go instead

news 3 hours ago

Chasing work-life balance can ‘lead to anxiety,' Harvard professor says—try the ‘pendulum lifestyle' instead

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Also on CNBC

• Cramer names four worthwhile stocks that were 'lost in the Nvidia shuffle'
• CEO says CrowdStrike is 'willing and open' to a resolution with Delta
• Salesforce CEO explains how customers use new platform 'Agentforce'

Subscribe to the CNBC YouTube Channel

Morning Squawk Newsletter